2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells

dc.creatorQuezada, M.
dc.creatorDiaz, J.
dc.creatorHenriquez, S.
dc.creatorBravo Castillo, María Loreto
dc.creatorAranda, E.
dc.creatorOliva, B.
dc.creatorVillalón, Manuel J.
dc.creatorKato Cardemil, Sumie Rode
dc.creatorCuello F., Mauricio
dc.creatorBrosens, J. J.
dc.creatorLange, C. A.
dc.creatorOwen, Gareth Ivor
dc.date.accessioned2020-01-08T02:11:06Z
dc.date.available2020-01-08T02:11:06Z
dc.date.created2020-01-08T02:11:06Z
dc.date.issued2010
dc.identifier10.1007/s12672-010-0019-5
dc.identifierhttps://repositorio.uc.cl/handle/11534/27179
dc.identifierhttps://doi.org/10.1007/s12672-010-0019-5
dc.description.abstract2-Methoxyestradiol (2ME) is an endogenous metabolite of 17β-estradiol with antiangiogenic and antitumor properties, although its mechanisms of action remain unclear. Progestins in hormone replacement therapy increase the risk of breast cancer. Progesteron
dc.languageen
dc.rightsacceso abierto
dc.subject2-Methoxyestradiol
dc.subjectBreast cancer
dc.subjectProgesterone receptor
dc.subjectSTAT5
dc.subjectTissue factor
dc.title2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells
dc.typeartículo


Este ítem pertenece a la siguiente institución